UCLA to launch Genetic Signatures technology
Filed with ASX · · 2 pages · English
• UCLA successfully completes Genetic Signatures product trial • Study demonstrates GSS 3Base™ technology & products as globally impactful • Trial results to be officially published by UCLA Sydney, Australia, 24 June 2016: Molecular diagnostics company Genetic Signatures Ltd (ASX: GSS) is pleased to announce that the University of California, Los Angeles (UCLA) has notified the Company that a rece
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- GSS launches Analyte Specific Reagents in US
- Collaboration with UCLA
- Appendix 4E and Audited Financial Report
Later from Genetic Signatures
- Completion of $14m capital raising
- Clinical Validation of Sexual Health Detection Kit Commenced
- Open Briefing - Capital Raising and Company Outlook
- STI Detection Kit Clinical Validation Trial Results
- 2016 AGM MD and CEO Presentation
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures